SAN RAMON, Calif., Nov. 1 /PRNewswire/ -- At this year’s Symposium of the National Society for Histotechnology (NSH), held in Fort Lauderdale, FL, BioGenex announced that it would be launching the Xmatrx(TM) Automated Staining System on January 1, 2006. Xmatrx(TM) is BioGenex’s new system for the complete automation of slide-based cell and tissue testing assays for molecular pathology applications, such as FISH, ISH and IHC.
“We are thrilled by the reception that the Xmatrx(TM) System has received,” said Krishan L. Kalra, Ph.D., CEO and Chairman of BioGenex. “This has been the best tradeshow in our history of almost 25 years. We have always been innovators in this field and we are on the verge of changing Immunohistochemistry yet again with the Xmatrx(TM) System, much like we changed the course of IHC when we invented Antigen Retrieval in the early 90’s.”
“The Xmatrx(TM) System will heavily impact the molecular diagnostics market,” said Carl Kunkleman, BioGenex Vice President of Sales. “We have exciting days ahead of us.”
About BioGenex
BioGenex, a technology leader in molecular pathology, provides Total Solution for complete automation of cell and tissue testing. The company offers a broad range of reagents and systems to streamline and standardize cellular and molecular diagnostics. BioGenex’s products are designed for high throughput at a low cost of ownership, providing ease of use and maximum flexibility for clinical diagnostics, life science research, and drug discovery.
BioGenex Laboratories, Inc.
CONTACT: media, Promila Rastogi, +1-925-866-2551, or financial, DavidSheldon, +1-925-543-1310, or business development, Shazi Iqbal,+1-925-866-2533, all for BioGenex Laboratories, Inc.
Web site: http://www.biogenex.com/
